PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 29 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $55,000 | -30.4% | 94,203 | 0.0% | 0.00% | – |
Q2 2017 | $79,000 | -43.2% | 94,203 | -7.9% | 0.00% | – |
Q1 2017 | $139,000 | -77.0% | 102,302 | -69.9% | 0.00% | -100.0% |
Q1 2015 | $604,000 | -3.4% | 339,555 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $625,000 | -24.0% | 339,555 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $822,000 | -38.7% | 339,555 | -7.5% | 0.00% | -50.0% |
Q2 2014 | $1,340,000 | -20.3% | 367,055 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $1,681,000 | +17.7% | 367,055 | 0.0% | 0.00% | +50.0% |
Q4 2013 | $1,428,000 | – | 367,055 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,825,000 | $1,206,000 | 0.39% |
Zhang Financial LLC | 45,000 | $33,000 | 0.02% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 472,553 | $313,000 | 0.01% |
MEITAV INVESTMENT HOUSE LTD | 127,062 | $85,000 | 0.01% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $215,000,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $200,000 | 0.00% |
Renaissance Technologies | 1,993,500 | $1,318,000 | 0.00% |
WEDBUSH SECURITIES INC | 15,000 | $10,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 57,127 | $38,000 | 0.00% |
Psagot Value Holdings Ltd. | 29,193 | $20,000 | 0.00% |